Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.
McBane RD 2nd, Loprinzi CL, Zemla T, Tafur A, Sanfilippo K, Liu JJ, Garcia DA, Heun J, Gundabolu K, Onitilo AA, Perepu U, Drescher MR, Henkin S, Houghton D, Ashrani A, Billett H, McCue SA, Lee MK, Le-Rademacher JG, Wysokinski WE; EVE trial investigators. McBane RD 2nd, et al. Among authors: loprinzi cl. J Thromb Haemost. 2024 Jun;22(6):1704-1714. doi: 10.1016/j.jtha.2024.03.011. Epub 2024 Mar 25. J Thromb Haemost. 2024. PMID: 38537780 Clinical Trial.
Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide.
Hazim A, Nhola LF, Kailash V, Zhang S, Sandhu NP, Lerman A, Loprinzi CL, Ruddy KJ, Villarraga HR, Lewis B, Herrmann J. Hazim A, et al. Among authors: loprinzi cl. Eur Heart J Open. 2023 Dec 8;4(1):oead130. doi: 10.1093/ehjopen/oead130. eCollection 2024 Jan. Eur Heart J Open. 2023. PMID: 38239934 Free PMC article.
Sexual Dysfunction in Patients With Metastatic Breast Cancer.
Jahan N, Cathcart-Rake E, Vierkant RA, Larson N, Loprinzi C, O'Sullivan CC, Faubion S, Kuhle C, Vencill JA, Couch F, Olson JE, Ruddy KJ. Jahan N, et al. Clin Breast Cancer. 2024 Jan;24(1):72-78.e4. doi: 10.1016/j.clbc.2023.09.018. Epub 2023 Oct 1. Clin Breast Cancer. 2024. PMID: 37867114
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients.
Minta A, Rose L, Park C, Ramaswamy B, Stover D, Gatti-Mays M, Cherian M, Williams N, Sudheendra P, Wesolowski R, Sardesai S, Lustberg M, Loprinzi CL, Ruddy KJ, Cathcart-Rake E, Trovato S, Dulmage B. Minta A, et al. Among authors: loprinzi cl. Support Care Cancer. 2023 Nov 22;31(12):717. doi: 10.1007/s00520-023-08160-0. Support Care Cancer. 2023. PMID: 37991653
Changes in amount and intensity of physical activity over time in breast cancer survivors.
Marell PS, Vierkant RA, Olson JE, Herrmann J, Larson NL, Lebrasseur NK, D'Andre SD, Ehlers DK, Stan DL, Cheville AL, Barksdale T, Loprinzi CL, Couch FJ, Ruddy KJ. Marell PS, et al. Among authors: loprinzi cl. JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad056. doi: 10.1093/jncics/pkad056. JNCI Cancer Spectr. 2023. PMID: 37561108 Free PMC article.
Eyebrow and Eyelash Loss in Patients With Cancer.
Rose L, Khuhro A, Minta A, Novice M, Novice T, Lustberg MB, Ruddy KJ, Rake EC, Loprinzi CL, Dulmage B. Rose L, et al. Among authors: loprinzi cl. J Drugs Dermatol. 2024 May 1;23(5):327-331. doi: 10.36849/JDD.8003. J Drugs Dermatol. 2024. PMID: 38709698 Review.
446 results